Partnering on the Front Line of Intensive Care
Vantive’s acute therapy systems help clinicians individualize organ support therapy for their patients, while streamlining the complexities of critical care.
Important Safety Information
INTENDED USE
The Prismaflex and PrisMax Systems are intended for:
Continuous Renal Replacement Therapy (CRRT) for patients weighing 20 kilograms or more with acute renal failure and/or fluid overload.
Therapeutic Plasma Exchange (TPE) therapy for patients weighing 20 kilograms or more with diseases where fluid removal of plasma components is indicated.
Rx Only. For safe and proper use of the products mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.
Vantive, Prismaflex and PrisMax are trademarks of Vantive Health LLC or its affiliates.